IDEX CORP /DE/
For the period ended Sep 30, 2025. Filed Oct 29, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Oct 29, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(In millions)
| Nine Months Ended September 30, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities | ||
| Net income | $354.2 | $381.4 |
| Adjustments to reconcile net income to net cash flows provided by operating activities: | ||
| Gain on sale of business | — | (4.0) |
| Asset impairments | 0.7 | — |
| Depreciation | 56.5 | 49.9 |
| Amortization of intangible assets | 96.5 | 75.0 |
| Share-based compensation expense | 23.7 | 20.9 |
| Deferred income taxes | (1.0) | 0.4 |
| Changes in (net of the effect from acquisitions/divestitures and foreign currency translation): | ||
| Receivables – net | (20.2) | (14.5) |
| Inventories – net | (49.4) | (21.6) |
| Other current assets | (1.4) | (4.6) |
| Trade accounts payable | (1.1) | 15.3 |
| Deferred revenue | (1.1) | (4.3) |
| Accrued expenses | 10.4 | (0.5) |
| Other – net | 3.1 | 2.1 |
| Net cash flows provided by operating activities | 470.9 | 495.5 |
| Cash flows from investing activities | ||
| Capital expenditures | (43.9) | (49.6) |
| Acquisition of business, net of cash acquired | (76.5) | (984.5) |
| Proceeds from sale of business, net of cash remitted | — | 45.1 |
| Other – net | 0.4 | (2.8) |
| Net cash flows used in investing activities | (120.0) | (991.8) |
| Cash flows from financing activities | ||
| Borrowings under revolving credit facilities | 197.0 | 279.3 |
| Proceeds from issuance of long-term borrowings | — | 496.7 |
| Payment of long-term borrowings | (100.0) | (25.0) |
| Payments under revolving credit facilities | (185.8) | — |
| Debt issuance costs | — | (1.2) |
| Cash dividends paid to shareholders | (159.4) | (153.0) |
| (Payments) proceeds from share issuances, net of shares withheld for taxes | (1.2) | 10.5 |
| Repurchases of common stock | (175.0) | — |
| Other – net | (0.5) | (0.6) |
| Net cash flows (used in) provided by financing activities | (424.9) | 606.7 |
| Effect of exchange rate changes on cash and cash equivalents | 34.8 | 6.6 |
| Net (decrease) increase in cash and cash equivalents and restricted cash | (39.2) | 117.0 |
| Cash and cash equivalents and restricted cash at beginning of year(1) | 638.9 | 534.3 |
| Cash and cash equivalents and restricted cash at end of period(1) | $599.7 | $651.3 |
| Supplemental cash flow information | ||
| Cash paid for: | ||
| Interest | $52.1 | $25.5 |
| Income taxes – net | 103.3 | 120.2 |
(1) Includes $5.9 million of restricted cash at September 30, 2025 and $18.1 million at both September 30, 2024 and December 31, 2024. At September 30, 2025, $3.0 million of the restricted cash has been included in Other current assets and $2.9 million has been included in Other noncurrent assets in the Condensed Consolidated Balance Sheets. At September 30, 2024 and December 31, 2024, $18.1 million was included in Other current assets in the Condensed Consolidated Balance Sheets. There wasno restricted cash as of December 31, 2023.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.